Tilray Inc (NASDAQ:TLRY - Get Free Report)'s share price fell 1.3% during trading on Friday . The stock traded as low as $0.40 and last traded at $0.41. 3,672,167 shares changed hands during mid-day trading, a decline of 87% from the average session volume of 28,978,496 shares. The stock had previously closed at $0.42.
Analysts Set New Price Targets
Several research firms recently commented on TLRY. Roth Capital reiterated a "neutral" rating on shares of Tilray in a research note on Monday, April 14th. Piper Sandler dropped their target price on Tilray from $2.00 to $1.00 and set a "neutral" rating for the company in a research note on Wednesday, April 9th.
Check Out Our Latest Research Report on Tilray
Tilray Stock Down 3.0%
The firm has a 50-day moving average of $0.45 and a 200 day moving average of $0.82. The stock has a market capitalization of $406.62 million, a price-to-earnings ratio of -1.35 and a beta of 1.83. The company has a current ratio of 2.54, a quick ratio of 1.58 and a debt-to-equity ratio of 0.10.
Tilray (NASDAQ:TLRY - Get Free Report) last released its quarterly earnings results on Tuesday, April 8th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.04) by ($0.06). The company had revenue of $185.78 million for the quarter, compared to analyst estimates of $213.38 million. Tilray had a negative return on equity of 4.40% and a negative net margin of 30.95%. On average, sell-side analysts anticipate that Tilray Inc will post -0.2 earnings per share for the current year.
Hedge Funds Weigh In On Tilray
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Lido Advisors LLC acquired a new position in shares of Tilray in the 4th quarter valued at approximately $28,000. Verdence Capital Advisors LLC acquired a new position in shares of Tilray in the 4th quarter valued at approximately $29,000. Dudley Capital Management LLC acquired a new position in shares of Tilray in the 4th quarter valued at approximately $29,000. Cerity Partners LLC acquired a new position in shares of Tilray in the 1st quarter valued at approximately $31,000. Finally, Capital Management Associates Inc raised its position in shares of Tilray by 100.0% in the 1st quarter. Capital Management Associates Inc now owns 50,760 shares of the company's stock valued at $33,000 after purchasing an additional 25,380 shares in the last quarter. 9.35% of the stock is owned by institutional investors and hedge funds.
About Tilray
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Read More
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
